Cristina Larkin - Net Worth and Insider Trading
Cristina Larkin Net Worth
The estimated net worth of Cristina Larkin is at least $1,973 dollars as of 2024-11-13. Cristina Larkin is the COO of Spero Therapeutics Inc and owns about 1,500 shares of Spero Therapeutics Inc (SPRO) stock worth over $1,973. Details can be seen in Cristina Larkin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cristina Larkin has not made any transactions after 2020-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cristina Larkin
Cristina Larkin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cristina Larkin owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .
Click here to see the complete history of Cristina Larkin’s form 4 insider trades.
Insider Ownership Summary of Cristina Larkin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2020-12-16 | Chief Operating Officer |
Cristina Larkin Latest Holdings Summary
Cristina Larkin currently owns a total of 1 stock. Cristina Larkin owns 1,500 shares of Spero Therapeutics Inc (SPRO) as of December 16, 2020, with a value of $1,973.
Latest Holdings of Cristina Larkin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2020-12-16 | 1,500 | 1.32 | 1,973 |
Holding Weightings of Cristina Larkin
Cristina Larkin Form 4 Trading Tracker
According to the SEC Form 4 filings, Cristina Larkin has made a total of 1 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 12,000 shares on December 16, 2020, which brought Cristina Larkin around $228,000.
Insider Trading History of Cristina Larkin
- 1
Cristina Larkin Trading Performance
GuruFocus tracks the stock performance after each of Cristina Larkin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cristina Larkin is -0.08%. GuruFocus also compares Cristina Larkin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cristina Larkin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cristina Larkin's insider trading performs compared to the benchmark.
Performance of Cristina Larkin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.67 | | | | | |
| Relative Return to S&P 500(%) | -6.14 | | | | | |
Cristina Larkin Ownership Network
Ownership Network List of Cristina Larkin
Ownership Network Relation of Cristina Larkin
Cristina Larkin Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Cristina Larkin is the Chief Operating Officer of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , director & See Remarks Ankit Mahadevia , and Chief Financial Officer Sath Shukla .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Cristina Larkin made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .
In summary, during the past 3 months, insiders sold 10,882 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 10,882 shares. During the past 18 months, 331,325 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 331,325 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Cristina Larkin Mailing Address
Above is the net worth, insider trading, and ownership report for Cristina Larkin. You might contact Cristina Larkin via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Avenue, 14th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
